Catalyst Pharmaceuticals

Logo GlobeNewswire
SciencePress Release2023-03-24 07:00:00
LONDON and NEW YORK, March 24, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (OKYO or the Company), an ophthalmology-focused...

Logo GlobeNewswire
SciencePress Release2023-03-23 20:01:00
New Drug Application and Marketing Authorization Application for neffy Currently Under Review with the FDA and EMA; FDA PDUFA Target Action Date Anticipated...

Logo NewsFileCorp
Press Release2023-03-24 07:15:00
Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that it has obtained a...

Logo Nasdaq
TechnologyBy Zacks2023-03-24 11:07:00
For Immediate Release Chicago, IL March 24, 2023 Today, Zacks Equity Research discusses for Chemed Corp. CHE, Addus HomeCare Corp. ADUS, RadNet, Inc. RDNT...

Logo GlobeNewswire
SciencePress Release2023-03-24 11:00:00
TREK-AD Phase 2b study of eblasakimab fully enrolled, topline data readout expected early July 2023 Phase 2 proof-of-concept trial of farudodstat in alopecia...

Logo EIN Presswire
Amines Market Amines are intermediates chemical compound that is used in the manufacturing of other chemical products. BURLINGAME, CALIFORNIA, UNITED STATES,...

Logo PR Newswire
HealthPress Release2023-03-24 11:00:00
CAMBRIDGE, Mass., March 24, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and...

Logo GlobeNewswire
SciencePress Release2023-03-23 20:05:00
BOSTON, March 23, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of...

Logo Benzinga
Business / FinanceBy Globe Newswire2023-03-24 11:00:00
TREK-AD Phase 2b study of fully enrolled, topline data readout expected early July 2023 Phase 2 proof-of-concept trial of in alopecia areata expected to...

Logo CBC
Business / FinanceBy Jenny Cowley2023-03-24 08:00:00
Shoppers Drug Mart is taking action following an investigation by CBC's Marketplace that found painkillers labelled as a treatment for menstrual cramps cost...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-23 20:01:00
Better Therapeutics, Inc. BTTX, a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive...

Logo GlobeNewswire
SciencePress Release2023-03-24 12:17:00
Trudhesa Achieved nTRx of Over 58.4K in 2022; nTRx Increased by 19.4% in Q4 vs. Q3 2022 Net Product Revenue Finished Year at $12.7 Million; Increased 62% in...

Logo NewsFileCorp
Press Release2023-03-24 14:58:00
Warsaw, Indiana--(Newsfile Corp. - March 24, 2023) - DuPont Advisory Group is proud to announce the launch of its advanced tax reduction planning and risk...

Logo GlobeNewswire
SciencePress Release2023-03-24 18:00:00
Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital...

Logo GlobeNewswire
SciencePress Release2023-03-23 21:05:00
NEW HAVEN, Conn., March 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the Company or Bioasis), a multi-asset rare and...

Logo PR Newswire
HealthPress Release2023-03-23 20:05:00
- Annual Net Product Sales Across the Company Grew 25% to $107.7 million in 2022, Compared to Annual Net Product Sales in 2021 - - APONVIE ™ Commercially...

Logo GlobeNewswire
EntertainmentPress Release2023-03-23 20:00:00
New to The Street Sign Acurx Pharmaceuticals, Inc. to Additional Six-Month Media Contract with Iconic Billboard Ads and Commercial Support FMW Media's...

Logo EIN Presswire
HealthPress Release2023-03-24 13:41:23
CAMBRIDGE, MA, UNITED STATES, March 24, 2023/ EINPresswire.com / -- Alphageneron Pharmaceuticals, Inc., (Alphageneron or the Company), a clinical-stage...

Logo PR Newswire
FORT LAUDERDALE, Fla. and SACRAMENTO, Calif., March 24, 2023 /PRNewswire/ -- Gemini BioProducts Holding, Inc. ("GeminiBio" or the "Company"), a portfolio...

Logo EIN Presswire
Global Sulfadiazine Market 2022 Research with COVID-19 Impact Analysis - Segmentation, Regional Outlook and Competition Analysis to 2032 NEW YORK CITY, NEW...